IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer

Yousefi, H. and Momeny, M. and Ghaffari, S. H. and Parsanejad, N. and Poursheikhani, A. and Javadikooshesh, S. and Zarrinrad, G. and Esmaeili, F. and Alishahi, Z. and Sabourinejad, Z. and Sankanian, G. and Shamsaiegahkani, S. and Bashash, D. and Shahsavani, N. and Tavakkoly-Bazzaz, J. and Alimoghaddam, K. and Ghavamzadeh, A. (2019) IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer. Tumori, 105 (1). pp. 84-91.

Full text not available from this repository.
Official URL: https://journals.sagepub.com/doi/full/10.1177/0300...
Item Type: Article
Additional Information: Cited By :5 Export Date: 26 September 2020
Subjects: WP Gynecology
QZ pathology-neoplasms-Genetics
Divisions: Mashhad University of Medical Sciences
Depositing User: lib2 lib2 lib2
Date Deposited: 04 Oct 2020 08:27
Last Modified: 04 Oct 2020 08:27
URI: http://eprints.mums.ac.ir/id/eprint/28439

Actions (login required)

View Item View Item